Miller Aine 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Miller Aine（CIK 2012524）在 1 家公司共报告 10 笔 SEC Form 4 内部人交易（最近一笔 2026-09-24）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 卖出 | 93,108 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 卖出 | 96,718 | $0 |
| 2026-08-24 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 卖出 | 6,258 | $106,073 |
| 2026-06-23 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 买入 | 18,750 | $0 |
| 2026-05-22 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 卖出 | 6,827 | $112,987 |
| 2026-02-24 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 卖出 | 16,851 | $331,291 |
| 2025-11-24 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 卖出 | 6,989 | $125,103 |
| 2025-08-22 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 卖出 | 6,989 | $93,583 |
| 2025-05-21 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 买入 | 10,430 | $0 |
| 2025-05-21 | Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 卖出 | 9,701 | $91,674 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24